Key facts
- It has raised $18.2M; the latest was Project Financing ($330K) in Aug 2024.
- Notable investors include Nimb Capital, Altitude Investment Management, Artemis Growth Partners, Enexis (Sweden), Greenfield Global.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Valcon Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Valcon Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Valcon Medical
Manufacturer of a medical cannabis product intended for medicinal purposes. The company offers a complete outsourcing method covering every phase from formulation and development to the delivery of a finished product, provides contract processing services, white label products, and bulk cannabis extract meticulously made to comply with the specific registrations of our partner's organizations and is licensed to produce medical cannabis extracts and to manufacture intermediate products under EU GMP standards, enabling patients and customers with product, consistently without compromising availability.
- Sector
- Healthcare
- HQ
- Lynge, Denmark
- Founded
- 2018
- Employees
- 12
- Website
- valcon-medical.com/
- Ownership
- Privately Held (backing)
Valcon Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Valcon Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Valcon Medical in its N-PORT filings yet. We sweep new filings monthly.